Persistent & Resistant Infections
Chronic & Multidrug-Resistant Infections
Research on persistent and multidrug-resistant infections within the Rare & Resistant Research Platform — focusing on patient experience, diagnostic delay, access barriers and real-world implementation across health systems, with a particular focus on conditions such as multidrug-resistant urinary tract infections (MDR UTIs).
Patient-centred approach
The programme follows a patient-centred approach and is informed by close exchange with patient communities and self-help organisations. Patient experience and real-world care pathways play a central role in identifying diagnostic delays, treatment barriers and unmet medical needs in multidrug-resistant UTIs.
Research programme
The research programme focuses on the analysis of care pathways, diagnostics and structural barriers in the management of multidrug-resistant urinary tract infections — including how patients move between outpatient care, specialist services, microbiology diagnostics and hospital treatment.
Research focus
Care pathways
Mapping of patient journeys to identify delays, fragmentation and bottlenecks across sectors (primary care, specialists, diagnostics and hospitals).
Diagnostics & access
Analysis of diagnostic pathways (incl. microbiology and resistance testing), access barriers and guideline implementation in real-world MDR UTI care.
Real-world evidence
Evidence synthesis with focus on implementation, access to effective therapies and real-world management strategies in resistant UTIs.
Programme development
The programme is currently being further developed and expanded, with additional research activities planned as the initiative grows.
Collaboration
We welcome scientific exchange and collaboration with clinicians and research groups working in antimicrobial resistance, chronic infections and implementation research.
Contact: info@mct8-research.com